Skip to main content

Table 6 Mean AUPRC on test sets from cross-validation for the ablation study

From: A fair experimental comparison of neural network architectures for latent representations of multi-omics for drug response prediction

Drug

Omics stacking

Complete integration

Without integration

Integration

Without triplet loss

Gemcitabine TCGA

0.143 ± 0.053

0.136 ± 0.054

0.161 ± 0.053

0.149 ± 0.074

Gemcitabine PDX

0.138 ± 0.046

0.204 ± 0.092

0.151 ± 0.085

0.119 ± 0.046

Cisplatin

0.288 ± 0.072

0.293 ± 0.074

0.293 ± 0.089

0.277 ± 0.084

Docetaxel

0.317 ± 0.064

0.262 ± 0.072

0.316 ± 0.083

0.358 ± 0.046

Erlotinib

0.422 ± 0.704

0.440 ± 0.149

0.479 ± 0.153

0.352 ± 0.111

Cetuximab

0.379 ± 0.102

0.264 ± 0.042

0.376 ± 0.104

0.350 ± 0.049

Paclitaxel

0.186 ± 0.076

0.188 ± 0.103

0.220 ± 0.108

0.090 ± 0.024

Rank

2.57

2.57

1.71

3.14

  1. Best results are shown in bold and second best are italic. The values represent the means and standard deviations over five iterations